(OKE) ONEOK - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6826801036
Stock: Natural Gas, NGLs, Refined Products, Crude, Storage
Total Rating 41
Risk 63
Buy Signal -0.16
| Risk 5d forecast | |
|---|---|
| Volatility | 27.5% |
| Relative Tail Risk | 2.12% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.05 |
| Alpha | -17.06 |
| Character TTM | |
|---|---|
| Beta | 0.668 |
| Beta Downside | 0.241 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.17% |
| CAGR/Max DD | 0.43 |
EPS (Earnings per Share)
Revenue
Description: OKE ONEOK March 01, 2026
ONEOK, Inc. (NYSE: OKE) is a U.S. midstream energy company that provides gathering, processing, fractionation, transportation, storage, and marine export services across four segments: Natural Gas Gathering & Processing, Natural Gas Liquids (NGL), Natural Gas Pipelines, and Refined Products & Crude. Its asset base spans the Mid-Continent, Permian Basin, North Texas, Gulf Coast, and Rocky Mountain regions, serving a broad client mix that includes E&P firms, utilities, petrochemical producers, and distributors.
In its latest fiscal year (2025), ONEOK reported adjusted EBITDA of $2.1 billion and generated $1.8 billion of free cash flow, supporting a 3.2% dividend yield and a leverage ratio of 2.1×. Pipeline utilization averaged 85%, while NGL prices have risen to roughly $1.45 per gallon, driven by strong demand for petrochemical feedstocks and higher LNG export volumes. The broader midstream sector benefits from rising natural gas prices (around $2.70/MMBtu) and continued capital spending on infrastructure to meet growing domestic and export demand.
For a deeper quantitative analysis, you might explore ONEOK’s profile on ValueRay.
Headlines to watch out for
- Natural gas and NGL prices impact revenue
- Regulatory changes affect pipeline operations
- Permian Basin production drives volume growth
- Interest rates influence financing costs
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 3.40b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.00 > 1.0 |
| NWC/Revenue: -5.58% < 20% (prev -2.22%; Δ -3.36% < -1%) |
| CFO/TA 0.14 > 3% & CFO 9.65b > Net Income 3.40b |
| Net Debt (32.74b) to EBITDA (7.79b): 4.20 < 3 |
| Current Ratio: 0.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (631.2m) vs 12m ago 7.62% < -2% |
| Gross Margin: 21.46% > 18% (prev 0.27%; Δ 2.12k% > 0.5%) |
| Asset Turnover: 51.46% > 50% (prev 33.87%; Δ 17.59% > 0%) |
| Interest Coverage Ratio: 3.52 > 6 (EBITDA TTM 7.79b / Interest Expense TTM 1.78b) |
Altman Z'' 0.63
| A: -0.03 (Total Current Assets 4.49b - Total Current Liabilities 6.37b) / Total Assets 66.64b |
| B: 0.04 (Retained Earnings 2.37b / Total Assets 66.64b) |
| C: 0.10 (EBIT TTM 6.27b / Avg Total Assets 65.36b) |
| D: 0.05 (Book Value of Equity 2.35b / Total Liabilities 44.07b) |
| Altman-Z'' Score: 0.63 = B |
Beneish M -2.65
| DSRI: 0.83 (Receivables 3.01b/2.33b, Revenue 33.63b/21.70b) |
| GMI: 1.24 (GM 21.46% / 26.57%) |
| AQI: 1.00 (AQ_t 0.21 / AQ_t-1 0.21) |
| SGI: 1.55 (Revenue 33.63b / 21.70b) |
| TATA: -0.09 (NI 3.40b - CFO 9.65b) / TA 66.64b) |
| Beneish M-Score: -2.65 (Cap -4..+1) = A |
What is the price of OKE shares?
As of March 14, 2026, the stock is trading at USD 85.76 with a total of 2,473,165 shares traded.
Over the past week, the price has changed by -1.81%, over one month by -0.87%, over three months by +18.81% and over the past year by -3.62%.
Over the past week, the price has changed by -1.81%, over one month by -0.87%, over three months by +18.81% and over the past year by -3.62%.
Is OKE a buy, sell or hold?
ONEOK has received a consensus analysts rating of 4.11.
Therefore, it is recommended to buy OKE.
- StrongBuy: 8
- Buy: 5
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OKE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 89.7 | 4.5% |
| Analysts Target Price | 89.7 | 4.5% |
OKE Fundamental Data Overview March 10, 2026
P/E Trailing = 16.0387
P/E Forward = 15.5521
P/S = 1.628
P/B = 2.4348
P/EG = 2.1811
Revenue TTM = 33.63b USD
EBIT TTM = 6.27b USD
EBITDA TTM = 7.79b USD
Long Term Debt = 30.75b USD (from longTermDebt, last quarter)
Short Term Debt = 2.06b USD (from shortTermDebt, last quarter)
Debt = 32.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 32.74b USD (from netDebt column, last quarter)
Enterprise Value = 87.49b USD (54.75b + Debt 32.82b - CCE 78.0m)
Interest Coverage Ratio = 3.52 (Ebit TTM 6.27b / Interest Expense TTM 1.78b)
EV/FCF = 20.26x (Enterprise Value 87.49b / FCF TTM 4.32b)
FCF Yield = 4.94% (FCF TTM 4.32b / Enterprise Value 87.49b)
FCF Margin = 12.84% (FCF TTM 4.32b / Revenue TTM 33.63b)
Net Margin = 10.10% (Net Income TTM 3.40b / Revenue TTM 33.63b)
Gross Margin = 21.46% ((Revenue TTM 33.63b - Cost of Revenue TTM 26.41b) / Revenue TTM)
Gross Margin QoQ = 29.44% (prev 19.17%)
Tobins Q-Ratio = 1.31 (Enterprise Value 87.49b / Total Assets 66.64b)
Interest Expense / Debt = 1.38% (Interest Expense 453.0m / Debt 32.82b)
Taxrate = 21.88% (274.0m / 1.25b)
NOPAT = 4.90b (EBIT 6.27b * (1 - 21.88%))
Current Ratio = 0.71 (Total Current Assets 4.49b / Total Current Liabilities 6.37b)
Debt / Equity = 1.46 (Debt 32.82b / totalStockholderEquity, last quarter 22.48b)
Debt / EBITDA = 4.20 (Net Debt 32.74b / EBITDA 7.79b)
Debt / FCF = 7.58 (Net Debt 32.74b / FCF TTM 4.32b)
Total Stockholder Equity = 21.94b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.19% (Net Income 3.40b / Total Assets 66.64b)
RoE = 15.47% (Net Income TTM 3.40b / Total Stockholder Equity 21.94b)
RoCE = 11.90% (EBIT 6.27b / Capital Employed (Equity 21.94b + L.T.Debt 30.75b))
RoIC = 8.96% (NOPAT 4.90b / Invested Capital 54.70b)
WACC = 5.64% (E(54.75b)/V(87.56b) * Re(8.38%) + D(32.82b)/V(87.56b) * Rd(1.38%) * (1-Tc(0.22)))
Discount Rate = 8.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.83%
[DCF] Terminal Value 88.43% ; FCFF base≈3.74b ; Y1≈4.61b ; Y5≈7.85b
[DCF] Fair Price = 311.1 (EV 228.66b - Net Debt 32.74b = Equity 195.92b / Shares 629.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 83.30 | EPS CAGR: 16.65% | SUE: 0.10 | # QB: 0
Revenue Correlation: 60.07 | Revenue CAGR: 13.41% | SUE: 1.14 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.41 | Chg7d=-0.030 | Chg30d=-0.030 | Revisions Net=-2 | Analysts=6
EPS current Year (2026-12-31): EPS=5.66 | Chg7d=-0.138 | Chg30d=-0.168 | Revisions Net=-8 | Growth EPS=+4.3% | Growth Revenue=-5.8%
EPS next Year (2027-12-31): EPS=6.09 | Chg7d=-0.178 | Chg30d=-0.209 | Revisions Net=-5 | Growth EPS=+7.8% | Growth Revenue=+10.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.1% (Discount Rate 8.4% - Earnings Yield 6.2%)
[Growth] Growth Spread = +7.2% (Analyst 9.4% - Implied 2.1%)
P/E Forward = 15.5521
P/S = 1.628
P/B = 2.4348
P/EG = 2.1811
Revenue TTM = 33.63b USD
EBIT TTM = 6.27b USD
EBITDA TTM = 7.79b USD
Long Term Debt = 30.75b USD (from longTermDebt, last quarter)
Short Term Debt = 2.06b USD (from shortTermDebt, last quarter)
Debt = 32.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 32.74b USD (from netDebt column, last quarter)
Enterprise Value = 87.49b USD (54.75b + Debt 32.82b - CCE 78.0m)
Interest Coverage Ratio = 3.52 (Ebit TTM 6.27b / Interest Expense TTM 1.78b)
EV/FCF = 20.26x (Enterprise Value 87.49b / FCF TTM 4.32b)
FCF Yield = 4.94% (FCF TTM 4.32b / Enterprise Value 87.49b)
FCF Margin = 12.84% (FCF TTM 4.32b / Revenue TTM 33.63b)
Net Margin = 10.10% (Net Income TTM 3.40b / Revenue TTM 33.63b)
Gross Margin = 21.46% ((Revenue TTM 33.63b - Cost of Revenue TTM 26.41b) / Revenue TTM)
Gross Margin QoQ = 29.44% (prev 19.17%)
Tobins Q-Ratio = 1.31 (Enterprise Value 87.49b / Total Assets 66.64b)
Interest Expense / Debt = 1.38% (Interest Expense 453.0m / Debt 32.82b)
Taxrate = 21.88% (274.0m / 1.25b)
NOPAT = 4.90b (EBIT 6.27b * (1 - 21.88%))
Current Ratio = 0.71 (Total Current Assets 4.49b / Total Current Liabilities 6.37b)
Debt / Equity = 1.46 (Debt 32.82b / totalStockholderEquity, last quarter 22.48b)
Debt / EBITDA = 4.20 (Net Debt 32.74b / EBITDA 7.79b)
Debt / FCF = 7.58 (Net Debt 32.74b / FCF TTM 4.32b)
Total Stockholder Equity = 21.94b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.19% (Net Income 3.40b / Total Assets 66.64b)
RoE = 15.47% (Net Income TTM 3.40b / Total Stockholder Equity 21.94b)
RoCE = 11.90% (EBIT 6.27b / Capital Employed (Equity 21.94b + L.T.Debt 30.75b))
RoIC = 8.96% (NOPAT 4.90b / Invested Capital 54.70b)
WACC = 5.64% (E(54.75b)/V(87.56b) * Re(8.38%) + D(32.82b)/V(87.56b) * Rd(1.38%) * (1-Tc(0.22)))
Discount Rate = 8.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.83%
[DCF] Terminal Value 88.43% ; FCFF base≈3.74b ; Y1≈4.61b ; Y5≈7.85b
[DCF] Fair Price = 311.1 (EV 228.66b - Net Debt 32.74b = Equity 195.92b / Shares 629.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 83.30 | EPS CAGR: 16.65% | SUE: 0.10 | # QB: 0
Revenue Correlation: 60.07 | Revenue CAGR: 13.41% | SUE: 1.14 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.41 | Chg7d=-0.030 | Chg30d=-0.030 | Revisions Net=-2 | Analysts=6
EPS current Year (2026-12-31): EPS=5.66 | Chg7d=-0.138 | Chg30d=-0.168 | Revisions Net=-8 | Growth EPS=+4.3% | Growth Revenue=-5.8%
EPS next Year (2027-12-31): EPS=6.09 | Chg7d=-0.178 | Chg30d=-0.209 | Revisions Net=-5 | Growth EPS=+7.8% | Growth Revenue=+10.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.1% (Discount Rate 8.4% - Earnings Yield 6.2%)
[Growth] Growth Spread = +7.2% (Analyst 9.4% - Implied 2.1%)